Wissen kompakt | Dokumentation in der Praxis: Fallstricke vermeiden
21. Februar 2026 | Hemoadsorption in cardiac surgery – New insights
28. Januar 2026 | Thema: Abrechnungsprüfung: Der juristische Ernstfall
CytoSorbents & Hemoadsorption
When it comes to critical health challenges, you can rely on us as your trusted partner.
We understand that healthcare professionals need to rely on advanced technologies designed to support high-quality patient care.
CytoSorbents’ adsorption technology is broadening the applications of blood purification, offering a mechanism to support physiological balance and assist in the management of harmful substances – complementary to conventional dialysis approaches.
Our Innovation
The Power of the Bead
Our solutions are based on proprietary, biocompatible, and highly porous polymer bead technology designed to reduce elevated levels of certain potentially harmful compounds from whole blood by hemoadsorption.
-
Our SolutionCytoSorb 300®
Learn more about CytoSorbSupporting balance. Protecting what matters.
*Not authorized / cleared / approved in the US
-
Our SolutionPuriFi
Learn more about PuriFiEnabling independent CytoSorb® Therapy
*Not authorized / cleared / approved for human use in the USA
-
Our SolutionECOS-300CY
Learn more about ECOSWorking with Ex Vivo Organ Perfusion to support the management of inflammatory processes
*Not authorized / cleared / approved in the US
-
Our SolutionVetResQ
Learn more about VetResQCytoSorb technology designed for veterinary critical-care applications
*Available only in the US
Use of CytoSorb in therapeutic areas
The CytoSorb adsorber serves as the basis for an extracorporeal blood purification therapy designed to reduce elevated levels of certain potentially harmful compounds from whole blood by hemoadsorption.
Our Team of Experts
Expertise you can count on the moment you need it.
